Eastman Chemical (EMN) Form 3 EASTMAN CHEMICAL / Michelle H Caveness ownership change

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0104
Estimated average burden
hours per response:	0.5

1. Name and Address of Reporting Person^*

Caveness Michelle H

(Last) (First) (Middle)

200 SOUTH WILCOX DRIVE

(Street)

KINGSPORT TN 37660

(City) (State) (Zip)

2. Date of Event Requiring Statement (Month/Day/Year)
01/01/2025

3. Issuer Name and Ticker or Trading Symbol
EASTMAN CHEMICAL CO [ EMN ]

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director	10% Owner
X	Officer (give title below)	Other (specify below)
SVP & Chf. Mgf. Ofc.

5. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Employee Stock Option (right to buy)	02/27/2025(1)	02/26/2034	Common Stock	3,425	86.15	D
Employee Stock Option (right to buy)	02/24/2024(2)	02/23/2033	Common Stock	2,295	83.84	D
Employee Stock Option (right to buy)	02/25/2023(3)	02/24/2032	Common Stock	1,984	120.8	D
Employee Stock Option (right to buy)	02/26/2022	02/25/2031	Common Stock	2,786	109.26	D
Restricted Stock Units	02/27/2027	02/27/2027	Common Stock	694	(4)	D
Restricted Stock Units	10/01/2025	10/01/2025	Common Stock	6,715	(4)	D

Explanation of Responses:

1. One-third of option becomes exercisable on February 27, 2025, February 27, 2026, and February 27, 2027.

2. One-third of option became exercisable on February 24, 2024, and one-third of option becomes exercisable on February 24, 2025, and February 24, 2026.

3. One-third of option became exercisable on February 25, 2023, one third of option became exercisable on February 25, 2024, and one-third of option becomes exercisable on February 25, 2025.

4. Restricted Stock Unit represents a contingent right to serve one share of issue common stock.

Remarks:

	/s/ Mark D. Austin, by Power of Attorney for Michelle H. Caveness	01/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.